ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of expanded labelling for its Ellipse™ implantable cardioverter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback